We’re Investigating Prior Authorization. Help ProPublica Understand Your Health Insurance Denial.
ProPublica is investigating the continued use of prior authorization by health insurers, a process requiring pre-approval for medical expenses. Despite insurers' pledges last year to reduce its use following backlash over delays and denials of critical care, data indicates the industry still relies heavily on this system.

Briefing Summary
AI-generatedProPublica is investigating the continued use of prior authorization by health insurers, a process requiring pre-approval for medical expenses. Despite insurers' pledges last year to reduce its use following backlash over delays and denials of critical care, data indicates the industry still relies heavily on this system. ProPublica is seeking firsthand accounts from individuals with Medicaid, Medicare, CHIP, or ACA marketplace plans who have experienced delayed or denied prior authorization requests. They are also interested in hearing from medical providers, insurance company employees, and regulators who have insight into the process. The goal is to understand the ongoing impact of prior authorization on patient access to treatments, tests, equipment, and medications.
Article analysis
Model · rule-basedKey claims
4 extractedProPublica is investigating how insurers' continued use of prior authorization is impacting patients.
Health insurers vowed to reduce their use of prior authorization after backlash from patients, providers, and politicians.
Data as of last year shows the industry is still relying heavily on the prior authorization process.
Prior authorization can delay or outright deny patients' critical medical care.